📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Enantigen

1.1 - Company Overview

Enantigen Logo

Enantigen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery, development, and commercialization of novel drugs for life-threatening infectious diseases, with a primary focus on oral therapeutics for the treatment of hepatitis; located at the Pennsylvania Biotechnology Center.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Enantigen

PaxVax Logo

PaxVax

HQ: United States Website
  • Description: Provider of candidate oral vaccines for influenza and other key infectious diseases, using a proprietary adenovirus-based oral vaccine technology that addresses delivery hurdles of traditional injectable vaccines, including the need for cold storage and needles.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PaxVax company profile →
Vaxcyte Logo

Vaxcyte

HQ: United States Website
  • Description: Provider of vaccines and vaccine development technologies, including VAX-24, a 24-valent pneumococcal conjugate vaccine for preventing invasive pneumococcal disease in adults (FDA Breakthrough Therapy); VAX-31, a 31-valent pneumococcal conjugate candidate; the XpressCF cell-free platform for site-specific conjugation to enhance immunogenicity; and preclinical programs for Group A Strep, periodontitis, and Shigella.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vaxcyte company profile →
Achaogen Logo

Achaogen

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development, discovering and developing broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Achaogen company profile →
Siga Technologies Logo

Siga Technologies

HQ: United States Website
  • Description: Provider of antiviral therapeutics for lethal pathogens, specializing in smallpox. Products include TPOXX (Tecovirimat-SIGA), approved for treatment of smallpox and, in various regions, monkeypox, cowpox, and vaccinia complications, and TPOXX Injection, an intravenous formulation for smallpox patients unable to swallow oral capsules.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Siga Technologies company profile →
Aethlon Medical Logo

Aethlon Medical

HQ: United States Website
  • Description: Provider of immunotherapeutic technologies to combat infectious disease and cancer, including the Hemopurifier, a device designed to rapidly remove cancer-promoting exosomes and circulating viruses from the bloodstream, currently under clinical trials for various cancers and viral infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aethlon Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Enantigen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Enantigen

2.2 - Growth funds investing in similar companies to Enantigen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Enantigen

4.2 - Public trading comparable groups for Enantigen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Enantigen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Enantigen

What does Enantigen do?

Enantigen is a provider of discovery, development, and commercialization of novel drugs for life-threatening infectious diseases, with a primary focus on oral therapeutics for the treatment of hepatitis; located at the Pennsylvania Biotechnology Center.

Who are Enantigen's competitors?

Enantigen's competitors and similar companies include PaxVax, Vaxcyte, Achaogen, Siga Technologies, and Aethlon Medical.

Where is Enantigen headquartered?

Enantigen is headquartered in United States.

How many employees does Enantigen have?

Enantigen has 1,000 employees 🔒.

When was Enantigen founded?

Enantigen was founded in 2010 🔒.

What sector and industry vertical is Enantigen in?

Enantigen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Enantigen

Who are the top strategic acquirers in Enantigen's sector and industry

Top strategic M&A buyers and acquirers in Enantigen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Enantigen?

Top strategic M&A buyers groups and sectors for Enantigen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Enantigen's sector and industry vertical

Which are the top PE firms investing in Enantigen's sector and industry vertical?

Top PE firms investing in Enantigen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Enantigen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Enantigen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Enantigen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Enantigen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Enantigen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Enantigen?

The key public trading comparables and valuation benchmarks for Enantigen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Enantigen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Enantigen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Enantigen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Enantigen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Enantigen's' sector and industry vertical?

Access recent funding rounds and capital raises in Enantigen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Enantigen